Bard Associates’s Transcat TRNS Stock Holding History

Bard Associates’s Portfolio TRNS Stock Details TRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.9K	Hold	150	–	–	﹤0.01%	213
2026 Q1	$11K	Hold	150	–	–	﹤0.01%	207
2025 Q4	$8.51K	Buy	+150	New	+$9.35K	﹤0.01%	212

Other funds holding TRNS

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bard Associates's TRNS Position: Q2 2026 in Review

Bard Associates held its Transcat (TRNS) position steady in Q2 2026 at 150 shares worth $13.9K. The position accounts for ﹤0.01% of the portfolio, ranked #213.

Bard Associates first reported a position in TRNS in Q4 2025 and has held it in 3 quarters since. 172 funds tracked by Wall St. Rank hold TRNS as of Q2 2026.

Bard Associates held 150 shares of Transcat worth $13.9K as of Q2 2026.
Bard Associates left its Transcat share count unchanged in Q2 2026.
Transcat made up ﹤0.01% of Bard Associates's portfolio in Q2 2026, its #213 holding.
Bard Associates first reported a position in Transcat in Q4 2025 and has held it in 3 quarters since.
172 funds tracked by Wall St. Rank held Transcat as of Q2 2026.

Based on Bard Associates's 13F filing for Q2 2026, filed 12 Aug 2026.